Publications

Publications from OUS - Section for Breast and Endocrine Surgery

149 publications found

Publications 2023

1. Riis ML, Augestad L, Flote VG, Tangerud A, Frich L (2023)
   Simultaneous cutaneous melanoma and ipsilateral breast cancer with metastasis to the same axilla. A case report with a focus on a multidisciplinary approach
   Int J Surg Case Rep, 114, 109119
   DOI 10.1016/j.ijscr.2023.109119, PubMed 38061088
2. Riis RN, Riis MH, Benth JŠ, Augestad KM (2023)
   Beyond the transanal total mesorectal excision moratorium: local and distant recurrence among patients operated for low rectal tumours-5-year follow-up from a Norwegian University Hospital
   Br J Surg, 110 (11), 1547-1548
   DOI 10.1093/bjs/znad275, PubMed 37672389
3. Sars C, Sackey H, Frisell J, Dickman PW, Karlsson F, Kindts I, Marta GN, Freitas-Junior R, Tvedskov TF, Kassem L, Ali AS, Ihalainen H, Neron M, Kontos M, Kaidar-Person O, Meattini I, Francken AB, van Duijnhoven F, Moberg IO, Marinko T, Kollar A, Ahmed M, Remoundos D, Banks J, Jagsi R et al. (2023)
   Current clinical practice in the management of phyllodes tumors of the breast: an international cross-sectional study among surgeons and oncologists
   Breast Cancer Res Treat, 199 (2), 293-304
   DOI 10.1007/s10549-023-06896-1, PubMed 36879102
4. Skjerven HK, Myklebust EM, Korvald C, Stubberud K, Hovda T, Porojnicu AC, Kaaresen R, Hofvind S, Schlicting E, Sahlberg KK (2023)
   Long-term follow-up of complex oncoplastic breast-conserving surgery, standard breast conservation and skin-sparing mastectomy in DCIS - a register-based study
   Eur J Surg Oncol, 50 (2), 107938
   DOI 10.1016/j.ejso.2023.107938, PubMed 38199004

Publications 2022

1. Frich PS, Sigstad E, Berstad AE, Fagerlid KH, Paulsen TH, Bjøro T, Flinder LI (2022)
   Long-Term Efficacy of Ethanol Ablation as Treatment of Metastatic Lymph Nodes From Papillary Thyroid Carcinoma
   J Clin Endocrinol Metab, 107 (5), e2141-e2147
   DOI 10.1210/clinem/dgab907, PubMed 34922379
2. Nilssen Y, Brustugun OT, Eriksen MT, Guren MG, Haug ES, Naume B, Schlichting E, Møller B (2022)
   Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015-2016
   BMC Cancer, 22 (1), 220
   DOI 10.1186/s12885-022-09306-9, PubMed 35227226
3. Riis M, Csanaky G, Lehne G, Tangerud A (2022)
   Anaplastic large cell lymphoma, ALK-negative of the breast diagnosed a short time after removal of breast implant in a patient with breast carcinoma: diagnostic and therapeutic considerations
   BMJ Case Rep, 15 (3)
   DOI 10.1136/bcr-2021-248232, PubMed 35236698
4. Schou-Bredal I, Sørensen EM, Kraglund KH, Jensen VS, Drageset S (2022)
   Development of the Breast Cancer Survivors Symptom Checklist for Use in Follow-Up Multidisciplinary Appointments
   Patient Relat Outcome Meas, 13, 199-208
   DOI 10.2147/PROM.S364625, PubMed 36238534
5. Skjerven HK, Danielsen AS, Schlichting E, Sahlberg KK, Hofvind S (2022)
   Treatment of Ductal Carcinoma in situ: A Register-Based Study of Norwegian Women Diagnosed between 1995 and 2018
   Breast Care (Basel), 17 (5), 486-494
   DOI 10.1159/000524564, PubMed 36684407
6. Skjerven HK, Myklebust EM, Korvald C, Porojnicu AC, Kaaresen R, Hofvind S, Schlicting E, Sahlberg KK (2022)
   Oncological outcomes after simple and skin-sparing mastectomy of ductal carcinoma in situ: A register-based cohort study of 576 Norwegian women
   Eur J Surg Oncol, 49 (3), 575-582
   DOI 10.1016/j.ejso.2022.11.594, PubMed 36509629
7. Strømsvik N, Olsson P, Gravdehaug B, Lurås H, Schlichting E, Jørgensen K, Wangensteen T, Vamre T, Heramb C, Mæhle L, Grindedal EM (2022)
   "It was an important part of my treatment": a qualitative study of Norwegian breast Cancer patients' experiences with mainstreamed genetic testing
   Hered Cancer Clin Pract, 20 (1), 6
   DOI 10.1186/s13053-022-00212-6, PubMed 35123550
8. Weider T, Genoni A, Broccolo F, Paulsen TH, Dahl-Jørgensen K, Toniolo A, Hammerstad SS (2022)
   High Prevalence of Common Human Viruses in Thyroid Tissue
   Front Endocrinol (Lausanne), 13, 938633
   DOI 10.3389/fendo.2022.938633, PubMed 35909527

Publications 2021

1. Banys-Paluchowski M, Gasparri ML, de Boniface J, Gentilini O, Stickeler E, Hartmann S, Thill M, Rubio IT, Di Micco R, Bonci EA, Niinikoski L, Kontos M, Karadeniz Cakmak G, Hauptmann M, Peintinger F, Pinto D, Matrai Z, Murawa D, Kadayaprath G, Dostalek L, Nina H, Krivorotko P, Classe JM, Schlichting E, Appelgren M et al. (2021)
   Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study
   Cancers (Basel), 13 (7)
   DOI 10.3390/cancers13071565, PubMed 33805367
2. Bonsaksen T, Ekeberg Ø, Schou-Bredal I, Skogstad L, Heir T, Grimholt TK (2021)
   Use of Alcohol and Addictive Drugs During the COVID-19 Outbreak in Norway: Associations With Mental Health and Pandemic-Related Problems
   Front Public Health, 9, 667729
   DOI 10.3389/fpubh.2021.667729, PubMed 34195169
3. Bonsaksen T, Skogstad L, Grimholt TK, Heir T, Ekeberg O, Lerdal A, Schou-Bredal I (2021)
   Substance use in the Norwegian general population: prevalence and associations with disease
   J. Subst. Use, 26 (2), 144-150
   DOI 10.1080/14659891.2020.1784303
4. Høghaug G, Skår R, Tran TN, Diep LM, Bredal IS (2021)
   Three-month follow-up effects of a medication management program on nurses' knowledge
   Nurse Educ Pract, 51, 102979
   DOI 10.1016/j.nepr.2021.102979, PubMed 33588183
5. Riis ML (2021)
   Management of patients with BRCA mutation from the point of view of a breast surgeon
   Ann Med Surg (Lond), 65, 102311
   DOI 10.1016/j.amsu.2021.102311, PubMed 33996049
6. Rye IH, Huse K, Josefsson SE, Kildal W, Danielsen HE, Schlichting E, Garred Ø, Riis ML, Osbreac, Lingjaerde OC, Myklebust JH, Russnes HG (2021)
   Breast cancer metastasis: immune profiling of lymph nodes reveals exhaustion of effector T cells and immunosuppression
   Mol Oncol, 16 (1), 88-103
   DOI 10.1002/1878-0261.13047, PubMed 34165864
7. Schou-Bredal I, Grimholt T, Bonsaksen T, Skogstad L, Heir T, Ekeberg Ø (2021)
   Optimists' and pessimists' self-reported mental and global health during the COVID-19 pandemic in Norway
   Health Psychol Rep, 9 (2), 160-168
   DOI 10.5114/hpr.2021.102394, PubMed 38084286
8. Stjernberg M, Schlichting E, Rustoen T, Valeberg BT, Småstuen MC, Raeder JC (2021)
   Postdischarge pain, nausea and patient satisfaction after diagnostic and breast-conserving ambulatory surgery for breast cancer: A cross-sectional study
   Acta Anaesthesiol Scand, 66 (3), 317-325
   DOI 10.1111/aas.14015, PubMed 34888855
9. Valsø Å, Rustøen T, Småstuen MC, Puntillo K, Skogstad L, Schou-Bredal I, Sunde K, Tøien K (2021)
   Occurrence and characteristics of pain after ICU discharge: A longitudinal study
   Nurs Crit Care, 27 (5), 718-727
   DOI 10.1111/nicc.12701, PubMed 34382725
10. Weider T, Richardson SJ, Morgan NG, Paulsen TH, Dahl-Jørgensen K, Hammerstad SS (2021)
    HLA Class I Upregulation and Antiviral Immune Responses in Graves Disease
    J Clin Endocrinol Metab, 106 (4), e1763-e1774
    DOI 10.1210/clinem/dgaa958, PubMed 33367784

Publications 2020

1. Bjerkeset E, Röhrl K, Schou-Bredal I (2020)
   Symptom cluster of pain, fatigue, and psychological distress in breast cancer survivors: prevalence and characteristics
   Breast Cancer Res Treat, 180 (1), 63-71
   DOI 10.1007/s10549-020-05522-8, PubMed 31938939
2. Bonsaksen T, Heir T, Skogstad L, Grimholt TK, Ekeberg O, Lerdal A, Schou-Bredal I (2020)
   Daily use of alcohol in the Norwegian general population: Prevalence and associated factors
   Drugs Alcohol Today, 20 (2), 109-121
   DOI 10.1108/DAT-02-2020-0010
3. Brunvoll SH, Thune I, Bertheussen GF, Fjeldheim F, Flote VG, Frydenberg H, Lundgren S, Skjerven H, Lømo J, Fagerland MW, McTiernan A, Schlichting E, Hjartåker A (2020)
   Dietary changes in early-stage breast cancer patients from pre-surgery and over the 12 months post-surgery
   Br J Nutr, 125 (2), 172-182
   DOI 10.1017/S0007114520002627, PubMed 32811572
4. Grindedal EM, Jørgensen K, Olsson P, Gravdehaug B, Lurås H, Schlichting E, Vamre T, Wangensteen T, Heramb C, Mæhle L (2020)
   Mainstreamed genetic testing of breast cancer patients in two hospitals in South Eastern Norway
   Fam Cancer, 19 (2), 133-142
   DOI 10.1007/s10689-020-00160-x, PubMed 32002722
5. Riis M (2020)
   Future perspectives of surgical treatment of breast cancer
   Ann Med Surg (Lond), 59, 93-95
   DOI 10.1016/j.amsu.2020.09.021, PubMed 33005399
6. Schou-Bredal I, Bonsaksen T, Ekeberg Ø, Skogstad L, Grimholt TK, Lerdal A, Heir T (2020)
   Sexual Assault and the Association With Health, Quality of Life, and Self-Efficacy in the General Norwegian Population
   J Interpers Violence, 37 (3-4), 1878-1901
   DOI 10.1177/0886260520926307, PubMed 32515259
7. Schou-Bredal I, Ekeberg Ø, Kåresen R (2020)
   Variability and stability of coping styles among breast cancer survivors: A prospective study
   Psychooncology, 30 (3), 369-377
   DOI 10.1002/pon.5587, PubMed 33167066
8. Skjerven HK, Danielsen AS, Schlichting E, Sahlberg KK, Hofvind S (2020)
   Surgical treatment of breast cancer in Norway 2003-2018
   Tidsskr Nor Laegeforen, 140 (15)
   DOI 10.4045/tidsskr.20.0090, PubMed 33118768
9. Sondén ECB, Sebuødegård S, Korvald C, Lømo J, Schlichting E, Brandal SHB, Hofvind S (2020)
   [Cosmetic breast implants and breast cancer]
   Tidsskr Nor Laegeforen, 140 (3)
   DOI 10.4045/tidsskr.19.0266, PubMed 32105043
10. Valsø Å, Rustøen T, Småstuen MC, Ekeberg Ø, Skogstad L, Schou-Bredal I, Myhren H, Sunde K, Tøien K (2020)
    Effect of Nurse-Led Consultations on Post-Traumatic Stress and Sense of Coherence in Discharged ICU Patients With Clinically Relevant Post-Traumatic Stress Symptoms-A Randomized Controlled Trial
    Crit Care Med, 48 (12), e1218-e1225
    DOI 10.1097/CCM.0000000000004628, PubMed 33048906
11. von der Lippe Gythfeldt H, Lien T, Tekpli X, Silwal-Pandit L, Borgen E, Garred Ø, Skjerven H, Schlichting E, Lundgren S, Wist E, Naume B, Kristensen V, Børresen-Dale AL, Lingjaerde OC, Engebraaten O (2020)
    Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER-positive breast cancer
    Int J Cancer, 147 (9), 2515-2525
    DOI 10.1002/ijc.33108, PubMed 32488909
12. Weider T, Richardson SJ, Morgan NG, Paulsen TH, Dahl-Jørgensen K, Hammerstad SS (2020)
    Upregulation of HLA Class I and Antiviral Tissue Responses in Hashimoto's Thyroiditis
    Thyroid, 30 (3), 432-442
    DOI 10.1089/thy.2019.0607, PubMed 31910110

Publications 2019

1. Bonsaksen T, Ekeberg Ø, Skogstad L, Heir T, Grimholt TK, Lerdal A, Schou-Bredal I (2019)
   Self-rated global health in the Norwegian general population
   Health Qual Life Outcomes, 17 (1), 188
   DOI 10.1186/s12955-019-1258-y, PubMed 31870385
2. Bonsaksen T, Heir T, Ekeberg Ø, Grimholt TK, Lerdal A, Skogstad L, Schou-Bredal I (2019)
   Self-evaluated anxiety in the Norwegian population: prevalence and associated factors
   Arch Public Health, 77, 10
   DOI 10.1186/s13690-019-0338-0, PubMed 30923612
3. Faye-Schjøll HH, Schou-Bredal I (2019)
   Pessimism predicts anxiety and depression in breast cancer survivors: A 5-year follow-up study
   Psychooncology, 28 (6), 1314-1320
   DOI 10.1002/pon.5084, PubMed 30950120
4. Grimholt TK, Bonsaksen T, Schou-Bredal I, Heir T, Lerdal A, Skogstad L, Ekeberg Ø (2019)
   Flight Anxiety Reported from 1986 to 2015
   Aerosp Med Hum Perform, 90 (4), 384-388
   DOI 10.3357/AMHP.5125.2019, PubMed 30922426
5. Hartmann-Johnsen OJ, Kåresen R, Schlichting E, Naume B, Nygård JF (2019)
   Using clinical cancer registry data for estimation of quality indicators: Results from the Norwegian breast cancer registry
   Int J Med Inform, 125, 102-109
   DOI 10.1016/j.ijmedinf.2019.03.004, PubMed 30914174
6. Heir T, Bonsaksen T, Grimholt T, Ekeberg Ø, Skogstad L, Lerdal A, Schou-Bredal I (2019)
   Serious life events and post-traumatic stress disorder in the Norwegian population
   BJPsych Open, 5 (5), e82
   DOI 10.1192/bjo.2019.62, PubMed 31506124
7. Høghaug G, Skår R, Tran TN, Schou-Bredal I (2019)
   Nurses' experiences with newly acquired knowledge about medication management: A qualitative study
   J Nurs Manag, 27 (8), 1731-1737
   DOI 10.1111/jonm.12864, PubMed 31495022
8. Johansson HJ, Socciarelli F, Vacanti NM, Haugen MH, Zhu Y, Siavelis I, Fernandez-Woodbridge A, Aure MR, Sennblad B, Vesterlund M, Branca RM, Orre LM, Huss M, Fredlund E, Beraki E, Garred Ø, Boekel J, Sauer T, Zhao W, Nord S, Höglander EK, Jans DC, Brismar H, Haukaas TH, Bathen TF et al. (2019)
   Breast cancer quantitative proteome and proteogenomic landscape
   Nat Commun, 10 (1), 1600
   DOI 10.1038/s41467-019-09018-y, PubMed 30962452
9. Opsahl EM, Akslen LA, Schlichting E, Aas T, Brauckhoff K, Hagen AI, Rosenlund AF, Sigstad E, Grøholt KK, Jørgensen LH, Bjøro T (2019)
   The Role of Calcitonin in Predicting the Extent of Surgery in Medullary Thyroid Carcinoma: A Nationwide Population-Based Study in Norway
   Eur Thyroid J, 8 (3), 159-166
   DOI 10.1159/000499018, PubMed 31259158
10. Schou-Bredal I, Bonsaksen T, Heir T, Skogstad L, Lerdal A, Grimholt T, Ekeberg O (2019)
    Optimists report fewer physical and mental health conditions than pessimists in the general Norwegian population
    HEALTH PSYCHOL. REP., 7 (1), 9-18
    DOI 10.5114/hpr.2019.81003
11. Shu X, Wu L, Khankari NK, Shu XO, Wang TJ, Michailidou K, Bolla MK, Wang Q, Dennis J, Milne RL, Schmidt MK, Pharoah PDP, Andrulis IL, Hunter DJ, Simard J, Easton DF, Zheng W, Breast Cancer Association Consortium (2019)
    Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis
    Int J Epidemiol, 48 (3), 795-806
    DOI 10.1093/ije/dyy201, PubMed 30277539
12. Tekpli X, Lien T, Røssevold AH, Nebdal D, Borgen E, Ohnstad HO, Kyte JA, Vallon-Christersson J, Fongaard M, Due EU, Svartdal LG, Sveli MAT, Garred Ø, OSBREAC, Frigessi A, Sahlberg KK, Sørlie T, Russnes HG, Naume B, Kristensen VN (2019)
    An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment
    Nat Commun, 10 (1), 5499
    DOI 10.1038/s41467-019-13329-5, PubMed 31796750

Publications 2018

1. Bonsaksen T, Grimholt TK, Skogstad L, Lerdal A, Ekeberg Ø, Heir T, Schou-Bredal I (2018)
   Self-diagnosed depression in the Norwegian general population - associations with neuroticism, extraversion, optimism, and general self-efficacy
   BMC Public Health, 18 (1), 1076
   DOI 10.1186/s12889-018-5990-8, PubMed 30157827
2. Bonsaksen T, Lerdal A, Heir T, Ekeberg Ø, Skogstad L, Grimholt TK, Schou-Bredal I (2018)
   General self-efficacy in the Norwegian population: Differences and similarities between sociodemographic groups
   Scand J Public Health, 47 (7), 695-704
   DOI 10.1177/1403494818756701, PubMed 29417880
3. Brunvoll SH, Thune I, Frydenberg H, Flote VG, Bertheussen GF, Schlichting E, Bjerve KS, Hjartåker A (2018)
   Validation of repeated self-reported n-3 PUFA intake using serum phospholipid fatty acids as a biomarker in breast cancer patients during treatment
   Nutr J, 17 (1), 94
   DOI 10.1186/s12937-018-0402-6, PubMed 30333016
4. Höglander EK, Nord S, Wedge DC, Lingjærde OC, Silwal-Pandit L, Gythfeldt HV, Vollan HKM, Fleischer T, Krohn M, Schlitchting E, Borgen E, Garred Ø, Holmen MM, Wist E, Naume B, Van Loo P, Børresen-Dale AL, Engebraaten O, Kristensen V (2018)
   Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations
   Genome Med, 10 (1), 92
   DOI 10.1186/s13073-018-0601-y, PubMed 30497530
5. Madssen TS, Thune I, Flote VG, Lundgren S, Bertheussen GF, Frydenberg H, Wist E, Schlichting E, Schäfer H, Fjøsne HE, Vettukattil R, Lømo J, Bathen TF, Giskeødegård GF (2018)
   Metabolite and lipoprotein responses and prediction of weight gain during breast cancer treatment
   Br J Cancer, 119 (9), 1144-1154
   DOI 10.1038/s41416-018-0211-x, PubMed 30401977
6. Moberg IO, Schou Bredal I, Schneider MR, Tønseth KA, Schlichting E (2018)
   Complications, risk factors, and patients-reported outcomes after skin-sparing mastectomy followed by breast reconstruction in women with BRCA mutations
   J Plast Surg Hand Surg, 52 (4), 234-239
   DOI 10.1080/2000656X.2018.1470093, PubMed 29741462
7. Norum J, Grindedal EM, Heramb C, Karsrud I, Ariansen SL, Undlien DE, Schlichting E, Mæhle L (2018)
   BRCA mutation carrier detection. A model-based cost-effectiveness analysis comparing the traditional family history approach and the testing of all patients with breast cancer
   ESMO Open, 3 (3), e000328
   DOI 10.1136/esmoopen-2018-000328, PubMed 29682331
8. Opsahl EM, Akslen LA, Schlichting E, Aas T, Brauckhoff K, Hagen AI, Rosenlund AF, Sigstad E, Grøholt KK, Mæhle L, Engebretsen LF, Jørgensen LH, Varhaug JE, Bjøro T (2018)
   Trends in Diagnostics, Surgical Treatment, and Prognostic Factors for Outcomes in Medullary Thyroid Carcinoma in Norway: A Nationwide Population-Based Study
   Eur Thyroid J, 8 (1), 31-40
   DOI 10.1159/000493977, PubMed 30800639
9. Tinholt M, Garred Ø, Borgen E, Beraki E, Schlichting E, Kristensen V, Sahlberg KK, Iversen N (2018)
   Subtype-specific clinical and prognostic relevance of tumor-expressed F5 and regulatory F5 variants in breast cancer: the CoCaV study
   J Thromb Haemost, 16 (7), 1347-1356
   DOI 10.1111/jth.14151, PubMed 29766637

Publications 2017

1. Aure MR, Vitelli V, Jernström S, Kumar S, Krohn M, Due EU, Haukaas TH, Leivonen SK, Vollan HK, Lüders T, Rødland E, Vaske CJ, Zhao W, Møller EK, Nord S, Giskeødegård GF, Bathen TF, Caldas C, Tramm T, Alsner J, Overgaard J, Geisler J, Bukholm IR, Naume B, Schlichting E et al. (2017)
   Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome
   Breast Cancer Res, 19 (1), 44
   DOI 10.1186/s13058-017-0812-y, PubMed 28356166
2. Bjørklund SS, Panda A, Kumar S, Seiler M, Robinson D, Gheeya J, Yao M, Alnæs GIG, Toppmeyer D, Riis M, Naume B, Børresen-Dale AL, Kristensen VN, Ganesan S, Bhanot G (2017)
   Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma
   Sci Rep, 7 (1), 5568
   DOI 10.1038/s41598-017-05537-0, PubMed 28717182
3. Dumeaux V, Fjukstad B, Fjosne HE, Frantzen JO, Holmen MM, Rodegerdts E, Schlichting E, Børresen-Dale AL, Bongo LA, Lund E, Hallett M (2017)
   Interactions between the tumor and the blood systemic response of breast cancer patients
   PLoS Comput Biol, 13 (9), e1005680
   DOI 10.1371/journal.pcbi.1005680, PubMed 28957325
4. Fleischer T, Klajic J, Aure MR, Louhimo R, Pladsen AV, Ottestad L, Touleimat N, Laakso M, Halvorsen AR, Grenaker Alnæs GI, Riis ML, Helland Å, Hautaniemi S, Lønning PE, Naume B, Børresen-Dale AL, Tost J, Kristensen VN (2017)
   DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival
   Oncotarget, 8 (1), 1074-1082
   DOI 10.18632/oncotarget.13718, PubMed 27911866
5. Fleischer T, Tekpli X, Mathelier A, Wang S, Nebdal D, Dhakal HP, Sahlberg KK, Schlichting E, Oslo Breast Cancer Research Consortium (OSBREAC), Børresen-Dale AL, Borgen E, Naume B, Eskeland R, Frigessi A, Tost J, Hurtado A, Kristensen VN (2017)
   DNA methylation at enhancers identifies distinct breast cancer lineages
   Nat Commun, 8 (1), 1379
   DOI 10.1038/s41467-017-00510-x, PubMed 29123100
6. Grindedal EM, Heramb C, Karsrud I, Ariansen SL, Mæhle L, Undlien DE, Norum J, Schlichting E (2017)
   Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers
   BMC Cancer, 17 (1), 438
   DOI 10.1186/s12885-017-3422-2, PubMed 28637432
7. Hartmann-Johnsen OJ, Kåresen R, Schlichting E, Nygård JF (2017)
   Better survival after breast-conserving therapy compared to mastectomy when axillary node status is positive in early-stage breast cancer: a registry-based follow-up study of 6387 Norwegian women participating in screening, primarily operated between 1998 and 2009
   World J Surg Oncol, 15 (1), 118
   DOI 10.1186/s12957-017-1184-6, PubMed 28673296
8. Hetmann F, Kongsgaard UE, Sandvik L, Schou-Bredal I (2017)
   Post-thoracotomy pain syndrome and sensory disturbances following thoracotomy at 6- and 12-month follow-ups
   J Pain Res, 10, 663-668
   DOI 10.2147/JPR.S126639, PubMed 28356766
9. Jiao X, Aravidis C, Marikkannu R, Rantala J, Picelli S, Adamovic T, Liu T, Maguire P, Kremeyer B, Luo L, von Holst S, Kontham V, Thutkawkorapin J, Margolin S, Du Q, Lundin J, Michailidou K, Bolla MK, Wang Q, Dennis J, Lush M, Ambrosone CB, Andrulis IL, Anton-Culver H, Antonenkova NN et al. (2017)
   PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1
   Oncotarget, 8 (61), 102769-102782
   DOI 10.18632/oncotarget.21800, PubMed 29262523
10. Ohnstad HO, Borgen E, Falk RS, Lien TG, Aaserud M, Sveli MAT, Kyte JA, Kristensen VN, Geitvik GA, Schlichting E, Wist EA, Sørlie T, Russnes HG, Naume B (2017)
    Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up
    Breast Cancer Res, 19 (1), 120
    DOI 10.1186/s13058-017-0911-9, PubMed 29137653
11. Silwal-Pandit L, Nord S, von der Lippe Gythfeldt H, Møller EK, Fleischer T, Rødland E, Krohn M, Borgen E, Garred Ø, Olsen T, Vu P, Skjerven H, Fangberget A, Holmen MM, Schlitchting E, Wille E, Nordberg Stokke M, Moen Vollan HK, Kristensen V, Langerød A, Lundgren S, Wist E, Naume B, Lingjærde OC, Børresen-Dale AL et al. (2017)
    The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer
    Clin Cancer Res, 23 (16), 4662-4670
    DOI 10.1158/1078-0432.CCR-17-0160, PubMed 28487444
12. Vaysse C, Lomo J, Garred O, Fjeldheim F, Lofteroed T, Schlichting E, McTiernan A, Frydenberg H, Husoy A, Lundgren S, Fagerland MW, Richardsen E, Wist EA, Muller C, Thune I (2017)
    Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer (vol 3, 35, 2017)
    npj Breast Cancer, 3, 35
    DOI 10.1038/s41523-017-0030-x
13. Vaysse C, Lømo J, Garred Ø, Fjeldheim F, Lofteroed T, Schlichting E, McTiernan A, Frydenberg H, Husøy A, Lundgren S, Fagerland MW, Richardsen E, Wist EA, Muller C, Thune I (2017)
    Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer
    NPJ Breast Cancer, 3, 19
    DOI 10.1038/s41523-017-0015-9, PubMed 28649659
14. Vaysse C, Lømo J, Garred Ø, Fjeldheim F, Lofteroed T, Schlichting E, McTiernan A, Frydenberg H, Husøy A, Lundgren S, Fagerland MW, Richardsen E, Wist EA, Muller C, Thune I (2017)
    Erratum: Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer
    NPJ Breast Cancer, 3, 35
    DOI 10.1038/s41523-017-0030-x, PubMed 28884144

Publications 2016

1. Flote VG, Vettukattil R, Bathen TF, Egeland T, McTiernan A, Frydenberg H, Husøy A, Finstad SE, Lømo J, Garred Ø, Schlichting E, Wist EA, Thune I (2016)
   Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer
   Lipids Health Dis, 15, 56
   DOI 10.1186/s12944-016-0225-4, PubMed 26970778
2. Hamdi Y, Soucy P, Adoue V, Michailidou K, Canisius S, Lemaçon A, Droit A, Andrulis IL, Anton-Culver H, Arndt V, Baynes C, Blomqvist C, Bogdanova NV, Bojesen SE, Bolla MK, Bonanni B, Borresen-Dale AL, Brand JS, Brauch H, Brenner H, Broeks A, Burwinkel B, Chang-Claude J, NBCS Collaborators, Couch FJ et al. (2016)
   Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21
   Oncotarget, 7 (49), 80140-80163
   DOI 10.18632/oncotarget.12818, PubMed 27792995
3. Haukaas TH, Euceda LR, Giskeødegård GF, Lamichhane S, Krohn M, Jernström S, Aure MR, Lingjærde OC, Schlichting E, Garred Ø, Due EU, Mills GB, Sahlberg KK, Børresen-Dale AL, Bathen TF, Oslo Breast Cancer Consortium (OSBREAC) (2016)
   Metabolic clusters of breast cancer in relation to gene- and protein expression subtypes
   Cancer Metab, 4, 12
   DOI 10.1186/s40170-016-0152-x, PubMed 27350877
4. Muranen TA, Greco D, Blomqvist C, Aittomäki K, Khan S, Hogervorst F, Verhoef S, Pharoah PDP, Dunning AM, Shah M, Luben R, Bojesen SE, Nordestgaard BG, Schoemaker M, Swerdlow A, García-Closas M, Figueroa J, Dörk T, Bogdanova NV, Hall P, Li J, Khusnutdinova E, Bermisheva M, Kristensen V, Borresen-Dale AL et al. (2016)
   Genetic modifiers of CHEK2*1100delC-associated breast cancer risk
   Genet Med, 19 (5), 599-603
   DOI 10.1038/gim.2016.147, PubMed 27711073
5. Opsahl EM, Brauckhoff M, Schlichting E, Helset K, Svartberg J, Brauckhoff K, Mæhle L, Engebretsen LF, Sigstad E, Grøholt KK, Akslen LA, Jørgensen LH, Varhaug JE, Bjøro T (2016)
   A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma
   Thyroid, 26 (9), 1225-38
   DOI 10.1089/thy.2015.0673, PubMed 27400880

Publications 2015

1. Hartmann-Johnsen OJ, Kåresen R, Schlichting E, Nygård JF (2015)
   Survival is Better After Breast Conserving Therapy than Mastectomy for Early Stage Breast Cancer: A Registry-Based Follow-up Study of Norwegian Women Primary Operated Between 1998 and 2008
   Ann Surg Oncol, 22 (12), 3836-45
   DOI 10.1245/s10434-015-4441-3, PubMed 25743325
2. Hetmann F, Kongsgaard UE, Sandvik L, Schou-Bredal I (2015)
   Prevalence and predictors of persistent post-surgical pain 12 months after thoracotomy
   Acta Anaesthesiol Scand, 59 (6), 740-8
   DOI 10.1111/aas.12532, PubMed 25907109
3. Kåresen R, Lunde C (2015)
   [Not Available]
   Tidsskr Nor Laegeforen, 135 (23-24), 2148-50
   DOI 10.4045/tidsskr.15.1176, PubMed 26674034
4. Silwal-Pandit L, Russnes H, Borgen E, Skarpeteig V, Moen Vollan HK, Schlichting E, Kåresen R, Naume B, Børresen-Dale AL, Farnebo M, Langerød A (2015)
   The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer
   PLoS One, 10 (10), e0139965
   DOI 10.1371/journal.pone.0139965, PubMed 26460974
5. Tinholt M, Vollan HK, Sahlberg KK, Jernström S, Kaveh F, Lingjærde OC, Kåresen R, Sauer T, Kristensen V, Børresen-Dale AL, Sandset PM, Iversen N (2015)
   Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF
   Breast Cancer Res, 17 (1), 44
   DOI 10.1186/s13058-015-0548-5, PubMed 25882602

Publications 2014

1. Dumeaux V, Ursini-Siegel J, Flatberg A, Fjosne HE, Frantzen JO, Holmen MM, Rodegerdts E, Schlichting E, Lund E (2014)
   Peripheral blood cells inform on the presence of breast cancer: a population-based case-control study
   Int J Cancer, 136 (3), 656-67
   DOI 10.1002/ijc.29030, PubMed 24931809
2. Fleischer T, Frigessi A, Johnson KC, Edvardsen H, Touleimat N, Klajic J, Riis ML, Haakensen VD, Wärnberg F, Naume B, Helland A, Børresen-Dale AL, Tost J, Christensen BC, Kristensen VN (2014)
   Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis
   Genome Biol, 15 (8), 435
   DOI 10.1186/PREACCEPT-2333349012841587, PubMed 25146004
3. Frydenberg H, Flote VG, Iversen A, Finstad SE, Furberg AS, Torjesen PA, Wilsgaard T, Schlichting E, Ellison PT, Ursin G, Thune I (2014)
   Insulin-like growth factor-1, growth hormone, and daily cycling estrogen are associated with mammographic density in premenopausal women
   Cancer Causes Control, 25 (7), 891-903
   DOI 10.1007/s10552-014-0389-z, PubMed 24801047
4. Glubb DM, Maranian MJ, Michailidou K, Pooley KA, Meyer KB, Kar S, Carlebur S, O'Reilly M, Betts JA, Hillman KM, Kaufmann S, Beesley J, Canisius S, Hopper JL, Southey MC, Tsimiklis H, Apicella C, Schmidt MK, Broeks A, Hogervorst FB, van der Schoot CE, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P et al. (2014)
   Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1
   Am J Hum Genet, 96 (1), 5-20
   DOI 10.1016/j.ajhg.2014.11.009, PubMed 25529635
5. Reiche K, Kasack K, Schreiber S, Lüders T, Due EU, Naume B, Riis M, Kristensen VN, Horn F, Børresen-Dale AL, Hackermüller J, Baumbusch LO (2014)
   Long non-coding RNAs differentially expressed between normal versus primary breast tumor tissues disclose converse changes to breast cancer-related protein-coding genes
   PLoS One, 9 (9), e106076
   DOI 10.1371/journal.pone.0106076, PubMed 25264628
6. Sagen A, Kaaresen R, Sandvik L, Thune I, Risberg MA (2014)
   Upper limb physical function and adverse effects after breast cancer surgery: a prospective 2.5-year follow-up study and preoperative measures
   Arch Phys Med Rehabil, 95 (5), 875-81
   DOI 10.1016/j.apmr.2013.12.015, PubMed 24389401
7. Schou Bredal I, Kåresen R, Smeby NA, Espe R, Sørensen EM, Amundsen M, Aas H, Ekeberg Ø (2014)
   Effects of a psychoeducational versus a support group intervention in patients with early-stage breast cancer: results of a randomized controlled trial
   Cancer Nurs, 37 (3), 198-207
   DOI 10.1097/NCC.0b013e31829879a3, PubMed 23782517
8. Schou Bredal I, Smeby NA, Ottesen S, Warncke T, Schlichting E (2014)
   Chronic pain in breast cancer survivors: comparison of psychosocial, surgical, and medical characteristics between survivors with and without pain
   J Pain Symptom Manage, 48 (5), 852-62
   DOI 10.1016/j.jpainsymman.2013.12.239, PubMed 24703940
9. Steindal SA, Bredal IS, Ranhoff AH, Sørbye LW, Lerdal A (2014)
   The last three days of life: a comparison of pain management in the young old and the oldest old hospitalised patients using the Resident Assessment Instrument for Palliative Care
   Int J Older People Nurs, 10 (4), 263-72
   DOI 10.1111/opn.12076, PubMed 25418556
10. Tinholt M, Viken MK, Dahm AE, Vollan HK, Sahlberg KK, Garred O, Børresen-Dale AL, Jacobsen AF, Kristensen V, Bukholm I, Kåresen R, Schlichting E, Skretting G, Lie BA, Sandset PM, Iversen N (2014)
    Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study
    BMC Cancer, 14, 845
    DOI 10.1186/1471-2407-14-845, PubMed 25407022

Publications 2013

1. Fosså A, Røsok BI, Kazaryan AM, Holte HJ, Brennhovd B, Westerheim O, Marangos IP, Edwin B (2013)
   Laparoscopic versus open surgery in stage I-III adrenocortical carcinoma -- a retrospective comparison of 32 patients
   Acta Oncol, 52 (8), 1771-7
   DOI 10.3109/0284186X.2013.765065, PubMed 23398621
2. Hagen AI, Mæhle L, Vedå N, Vetti HH, Stormorken A, Ludvigsen T, Guntvedt B, Isern AE, Schlichting E, Kleppe G, Bofin A, Gullestad HP, Møller P (2013)
   Risk reducing mastectomy, breast reconstruction and patient satisfaction in Norwegian BRCA1/2 mutation carriers
   Breast, 23 (1), 38-43
   DOI 10.1016/j.breast.2013.10.002, PubMed 24210736
3. Hannisdal E, Arianson H, Braut GS, Schlichting E, Vinnem JE (2013)
   A risk analysis of cancer care in Norway: the top 16 patient safety hazards
   Jt Comm J Qual Patient Saf, 39 (11), 511-6
   DOI 10.1016/s1553-7250(13)39067-9, PubMed 24294679
4. Hetmann F, Schou-Bredal I, Sandvik L, Kongsgaard UE (2013)
   Does chronic pre-operative pain predict severe post-operative pain after thoracotomy? A prospective longitudinal study
   Acta Anaesthesiol Scand, 57 (8), 1065-72
   DOI 10.1111/aas.12159, PubMed 23859248
5. Hofvind S, Schlichting E, Ursin G, Sebuødegård S, Kåresen R (2013)
   [Breast cancer surgery in Norway 1986-2009]
   Tidsskr Nor Laegeforen, 133 (15), 1582-6
   DOI 10.4045/tidsskr.12.0840, PubMed 23970271
6. Hovind IL, Bredal IS, Dihle A (2013)
   Women's experience of acute and chronic pain following breast cancer surgery
   J Clin Nurs, 22 (7-8), 1044-52
   DOI 10.1111/jocn.12167, PubMed 23480500
7. Synnestvedt M, Borgen E, Schlichting E, Schirmer CB, Renolen A, Giercksky KE, Nesland JM, Naume B (2013)
   Disseminated tumour cells in the bone marrow in early breast cancer: morphological categories of immunocytochemically positive cells have different impact on clinical outcome
   Breast Cancer Res Treat, 138 (2), 485-97
   DOI 10.1007/s10549-013-2439-8, PubMed 23456230

Publications 2012

1. Dhakal HP, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Bassarova A, Holm R, Giercksky KE, Nesland JM (2012)
   Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness
   Histopathology, 61 (3), 350-64
   DOI 10.1111/j.1365-2559.2012.04223.x, PubMed 22690749
2. Dhakal HP, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Bassarova A, Holm R, Giercksky KE, Nesland JM (2012)
   Expression of cyclooxygenase-2 in invasive breast carcinomas and its prognostic impact
   Histol Histopathol, 27 (10), 1315-25
   DOI 10.14670/HH-27.1315, PubMed 22936450
3. Mangiafico S, Costello-Boerrigter LC, Andersen IA, Cataliotti A, Burnett JC (2012)
   Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics
   Eur Heart J, 34 (12), 886-893c
   DOI 10.1093/eurheartj/ehs262, PubMed 22942338
4. Sahlberg KK, Hongisto V, Edgren H, Mäkelä R, Hellström K, Due EU, Moen Vollan HK, Sahlberg N, Wolf M, Børresen-Dale AL, Perälä M, Kallioniemi O (2012)
   The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells
   Mol Oncol, 7 (3), 392-401
   DOI 10.1016/j.molonc.2012.10.012, PubMed 23253899
5. Schou Bredal I, Kåresen R, Skaane P, Engelstad KS, Ekeberg Ø (2012)
   Recall mammography and psychological distress
   Eur J Cancer, 49 (4), 805-11
   DOI 10.1016/j.ejca.2012.09.001, PubMed 23021930
6. Steindal SA, Ranhoff AH, Bredal IS, Sørbye LW, Lerdal A (2012)
   Last three days of life in the hospital: a comparison of symptoms, signs and treatments in the young old and the oldest old patients using the Resident assessment instrument for palliative care
   Int J Older People Nurs, 8 (3), 199-206
   DOI 10.1111/j.1748-3743.2012.00313.x, PubMed 22329702
7. Synnestvedt M, Borgen E, Russnes HG, Kumar NT, Schlichting E, Giercksky KE, Kåresen R, Nesland JM, Naume B (2012)
   Combined analysis of vascular invasion, grade, HER2 and Ki67 expression identifies early breast cancer patients with questionable benefit of systemic adjuvant therapy
   Acta Oncol, 52 (1), 91-101
   DOI 10.3109/0284186X.2012.713508, PubMed 22934555

Publications 2011

1. Borgan E, Navon R, Vollan HK, Schlichting E, Sauer T, Yakhini Z, Lingjærde OC, Sørlie T, Børresen-Dale AL (2011)
   Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue
   Mol Oncol, 5 (6), 564-76
   DOI 10.1016/j.molonc.2011.08.004, PubMed 21917534
2. Chrisanthar R, Knappskog S, Løkkevik E, Anker G, Ostenstad B, Lundgren S, Risberg T, Mjaaland I, Skjønsberg G, Aas T, Schlichting E, Fjösne HE, Nysted A, Lillehaug JR, Lønning PE (2011)
   Predictive and prognostic impact of TP53 mutations and MDM2 promoter genotype in primary breast cancer patients treated with epirubicin or paclitaxel
   PLoS One, 6 (4), e19249
   DOI 10.1371/journal.pone.0019249, PubMed 21556366
3. Fjösne HE, Søreide JA, Kåresen R, Lønning PE, Jacobsen AB, Lundgren S, NORWEGIAN BREAST CANCER GROUP (NBCG) (2011)
   Hospital volume and prognosis among Norwegian breast cancer patients enrolled in adjuvant trials
   Acta Oncol, 50 (7), 1068-74
   DOI 10.3109/0284186X.2011.585998, PubMed 21745131
4. Molloy TJ, Bosma AJ, Baumbusch LO, Synnestvedt M, Borgen E, Russnes HG, Schlichting E, van't Veer LJ, Naume B (2011)
   The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients
   Breast Cancer Res, 13 (3), R61
   DOI 10.1186/bcr2898, PubMed 21672237
5. Stafseth SK, Solms D, Bredal IS (2011)
   The characterisation of workloads and nursing staff allocation in intensive care units: a descriptive study using the Nursing Activities Score for the first time in Norway
   Intensive Crit Care Nurs, 27 (5), 290-4
   DOI 10.1016/j.iccn.2011.07.003, PubMed 21871805
6. Steindal SA, Bredal IS, Sørbye LW, Lerdal A (2011)
   Pain control at the end of life: a comparative study of hospitalized cancer and noncancer patients
   Scand J Caring Sci, 25 (4), 771-9
   DOI 10.1111/j.1471-6712.2011.00892.x, PubMed 21564152
7. Steindal SA, Sørbye LW, Bredal IS, Lerdal A (2011)
   Agreement in documentation of symptoms, clinical signs, and treatment at the end of life: a comparison of data retrieved from nurse interviews and electronic patient records using the Resident Assessment Instrument for Palliative Care
   J Clin Nurs, 21 (9-10), 1416-24
   DOI 10.1111/j.1365-2702.2011.03867.x, PubMed 22023535
8. Suhrke P, Mæhlen J, Schlichting E, Jørgensen KJ, Gøtzsche PC, Zahl PH (2011)
   Effect of mammography screening on surgical treatment for breast cancer in Norway: comparative analysis of cancer registry data
   BMJ, 343, d4692
   DOI 10.1136/bmj.d4692, PubMed 21914765
9. Tveito S, Andersen K, Kåresen R, Fodstad Ø (2011)
   Analysis of EpCAM positive cells isolated from sentinel lymph nodes of breast cancer patients identifies subpopulations of cells with distinct transcription profiles
   Breast Cancer Res, 13 (4), R75
   DOI 10.1186/bcr2922, PubMed 21816090
10. Tøien K, Bredal IS, Skogstad L, Myhren H, Ekeberg O (2011)
    Health related quality of life in trauma patients. Data from a one-year follow up study compared with the general population
    Scand J Trauma Resusc Emerg Med, 19, 22
    DOI 10.1186/1757-7241-19-22, PubMed 21477280
11. Tøien K, Skogstad L, Ekeberg Ø, Myhren H, Schou Bredal I (2011)
    Prevalence and predictors of return to work in hospitalised trauma patients during the first year after discharge: a prospective cohort study
    Injury, 43 (9), 1606-13
    DOI 10.1016/j.injury.2011.03.038, PubMed 21489524
12. Vollan HK, Caldas C (2011)
    The breast cancer genome--a key for better oncology
    BMC Cancer, 11, 501
    DOI 10.1186/1471-2407-11-501, PubMed 22128823

Publications 2010

1. Bredal IS (2010)
   The Norwegian version of the Mini-Mental Adjustment to Cancer Scale: factor structure and psychometric properties
   Psychooncology, 19 (2), 216-21
   DOI 10.1002/pon.1564, PubMed 19378351
2. Bredal IS, Sandvik L, Karesen R, Ekeberg O (2010)
   Prognostic value of health-related quality-of-life parameters in early-stage breast cancer: an 8-year follow-up study
   Psychooncology, 20 (10), 1102-7
   DOI 10.1002/pon.1822, PubMed 20737644
3. Effenberger KE, Borgen E, Eulenburg CZ, Bartkowiak K, Grosser A, Synnestvedt M, Kaaresen R, Brandt B, Nesland JM, Pantel K, Naume B (2010)
   Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern
   Breast Cancer Res Treat, 125 (3), 729-38
   DOI 10.1007/s10549-010-0911-2, PubMed 20449649
4. Kamalakaran S, Varadan V, Giercksky Russnes HE, Levy D, Kendall J, Janevski A, Riggs M, Banerjee N, Synnestvedt M, Schlichting E, Kåresen R, Shama Prasada K, Rotti H, Rao R, Rao L, Eric Tang MH, Satyamoorthy K, Lucito R, Wigler M, Dimitrova N, Naume B, Borresen-Dale AL, Hicks JB (2010)
   DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables
   Mol Oncol, 5 (1), 77-92
   DOI 10.1016/j.molonc.2010.11.002, PubMed 21169070
5. Naume B, Zhao X, Synnestvedt M, Borgen E, Russnes HG, Lingjaerde OC, Stromberg M, Wiedswang G, Kvalheim G, Karesen R, Nesland JM, Borresen-Dale AL, Sorlie T (2010)
   Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer (vol 1, pg 160, 2007)
   Mol. Oncol., 4 (2), 169
   DOI 10.1016/j.molonc.2010.01.003
6. Rantala JK, Edgren H, Lehtinen L, Wolf M, Kleivi K, Vollan HK, Aaltola AR, Laasola P, Kilpinen S, Saviranta P, Iljin K, Kallioniemi O (2010)
   Integrative functional genomics analysis of sustained polyploidy phenotypes in breast cancer cells identifies an oncogenic profile for GINS2
   Neoplasia, 12 (11), 877-88
   DOI 10.1593/neo.10548, PubMed 21082043
7. Russnes HG, Vollan HKM, Lingjærde OC, Krasnitz A, Lundin P, Naume B, Sørlie T, Borgen E, Rye IH, Langerød A, Chin SF, Teschendorff AE, Stephens PJ, Månér S, Schlichting E, Baumbusch LO, Kåresen R, Stratton MP, Wigler M, Caldas C, Zetterberg A, Hicks J, Børresen-Dale AL (2010)
   Genomic architecture characterizes tumor progression paths and fate in breast cancer patients
   Sci Transl Med, 2 (38), 38ra47
   DOI 10.1126/scitranslmed.3000611, PubMed 20592421
8. Sørlie T, Borgan E, Myhre S, Vollan HK, Russnes H, Zhao X, Nilsen G, Lingjaerde OC, Børresen-Dale AL, Rødland E (2010)
   The importance of gene-centring microarray data
   Lancet Oncol, 11 (8), 719-20; author reply 720-1
   DOI 10.1016/S1470-2045(10)70174-1, PubMed 20688275
9. Tøien K, Myhren H, Bredal IS, Skogstad L, Sandvik L, Ekeberg Ø (2010)
   Psychological distress after severe trauma: a prospective 1-year follow-up study of a trauma intensive care unit population
   J Trauma, 69 (6), 1552-9
   DOI 10.1097/TA.0b013e3181e125f3, PubMed 20664371

Publications 2009

1. Dhakal HP, Bassarova A, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Giercksky KE, Nesland JM (2009)
   Breast carcinoma vascularity: a comparison of manual microvessel count and Chalkley count
   Histol Histopathol, 24 (8), 1049-59
   DOI 10.14670/HH-24.1049, PubMed 19554512
2. Emaus A, Veierød MB, Tretli S, Finstad SE, Selmer R, Furberg AS, Bernstein L, Schlichting E, Thune I (2009)
   Metabolic profile, physical activity, and mortality in breast cancer patients
   Breast Cancer Res Treat, 121 (3), 651-60
   DOI 10.1007/s10549-009-0603-y, PubMed 19882245
3. Kalager M, Kåresen R, Wist E (2009)
   [Survival after breast cancer--differences between Norwegian counties]
   Tidsskr Nor Laegeforen, 129 (24), 2595-600
   DOI 10.4045/tidsskr.09.0024, PubMed 20029554
4. Park D, Kåresen R, Naume B, Synnestvedt M, Beraki E, Sauer T (2009)
   The prognostic impact of occult nodal metastasis in early breast carcinoma
   Breast Cancer Res Treat, 118 (1), 57-66
   DOI 10.1007/s10549-009-0340-2, PubMed 19219629
5. Sagen A, Kåresen R, Risberg MA (2009)
   Physical activity for the affected limb and arm lymphedema after breast cancer surgery. A prospective, randomized controlled trial with two years follow-up
   Acta Oncol, 48 (8), 1102-10
   DOI 10.3109/02841860903061683, PubMed 19863217
6. Sagen A, Kåresen R, Sandvik L, Risberg MA (2009)
   Changes in arm morbidities and health-related quality of life after breast cancer surgery - a five-year follow-up study
   Acta Oncol, 48 (8), 1111-8
   DOI 10.3109/02841860903061691, PubMed 19863218
7. Sagen A, Kåresen R, Skaane P, Risberg MA (2009)
   Validity for the simplified water displacement instrument to measure arm lymphedema as a result of breast cancer surgery
   Arch Phys Med Rehabil, 90 (5), 803-9
   DOI 10.1016/j.apmr.2008.11.016, PubMed 19406300

Publications 2008

1. Dhakal HP, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Bassarova A, Giercksky KE, Nesland JM (2008)
   Vascularization in primary breast carcinomas: its prognostic significance and relationship with tumor cell dissemination
   Clin Cancer Res, 14 (8), 2341-50
   DOI 10.1158/1078-0432.CCR-07-4214, PubMed 18413823
2. Schou I, Ekeberg O, Karesen R, Sorensen E (2008)
   Psychosocial intervention as a component of routine breast cancer care-who participates and does it help?
   Psychooncology, 17 (7), 716-20
   DOI 10.1002/pon.1264, PubMed 18033695

Publications 2007

1. Chanock SJ, Burdett L, Yeager M, Llaca V, Langerød A, Presswalla S, Kaaresen R, Strausberg RL, Gerhard DS, Kristensen V, Perou CM, Børresen-Dale AL (2007)
   Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas
   Breast Cancer Res, 9 (1), R5
   DOI 10.1186/bcr1637, PubMed 17224074
2. Hval K, Thagaard KS, Schlichting E, Raeder J (2007)
   The prolonged postoperative analgesic effect when dexamethasone is added to a nonsteroidal antiinflammatory drug (rofecoxib) before breast surgery
   Anesth Analg, 105 (2), 481-6
   DOI 10.1213/01.ane.0000267261.61444.69, PubMed 17646509
3. Langerød A, Zhao H, Borgan Ø, Nesland JM, Bukholm IR, Ikdahl T, Kåresen R, Børresen-Dale AL, Jeffrey SS (2007)
   TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer
   Breast Cancer Res, 9 (3), R30
   DOI 10.1186/bcr1675, PubMed 17504517
4. Naume B, Zhao X, Synnestvedt M, Borgen E, Russnes HG, Lingjaerde OC, Strømberg M, Wiedswang G, Kvalheim G, Kåresen R, Nesland JM, Børresen-Dale AL, Sørlie T (2007)
   Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer
   Mol Oncol, 1 (2), 160-71
   DOI 10.1016/j.molonc.2007.03.004, PubMed 19383292
5. Park D, Kåresen R, Axcrona U, Noren T, Sauer T (2007)
   Expression pattern of adhesion molecules (E-cadherin, alpha-, beta-, gamma-catenin and claudin-7), their influence on survival in primary breast carcinoma, and their corresponding axillary lymph node metastasis
   APMIS, 115 (1), 52-65
   DOI 10.1111/j.1600-0463.2007.apm_524.x, PubMed 17223851
6. Park D, Kåresen R, Noren T, Sauer T (2007)
   Ki-67 expression in primary breast carcinomas and their axillary lymph node metastases: clinical implications
   Virchows Arch, 451 (1), 11-8
   DOI 10.1007/s00428-007-0435-2, PubMed 17554555

Publications 2006

1. Schlichting E, Harr ME, Sauer T, Babovic A, Kåresen R (2006)
   [Sentinel lymph node biopsy in breast cancer]
   Tidsskr Nor Laegeforen, 126 (16), 2098-100
   PubMed 16932777

Publications 2005

1. Kristensen VN, Sørlie T, Geisler J, Langerød A, Yoshimura N, Kåresen R, Harada N, Lønning PE, Børresen-Dale AL (2005)
   Gene expression profiling of breast cancer in relation to estrogen receptor status and estrogen-metabolizing enzymes: clinical implications
   Clin Cancer Res, 11 (2 Pt 2), 878s-83s
   PubMed 15701881
2. Lønning PE, Geisler J, Krag LE, Erikstein B, Bremnes Y, Hagen AI, Schlichting E, Lien EA, Ofjord ES, Paolini J, Polli A, Massimini G (2005)
   Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer
   J Clin Oncol, 23 (22), 5126-37
   DOI 10.1200/JCO.2005.07.097, PubMed 15983390
3. Sagen A, Kåresen R, Risberg MA (2005)
   The reliability of a simplified water displacement instrument: a method for measuring arm volume
   Arch Phys Med Rehabil, 86 (1), 86-9
   DOI 10.1016/j.apmr.2003.12.042, PubMed 15640996
4. Schou I, Ekeberg Ø, Ruland CM (2005)
   The mediating role of appraisal and coping in the relationship between optimism-pessimism and quality of life
   Psychooncology, 14 (9), 718-27
   DOI 10.1002/pon.896, PubMed 15669084
5. Sharma P, Sahni NS, Tibshirani R, Skaane P, Urdal P, Berghagen H, Jensen M, Kristiansen L, Moen C, Sharma P, Zaka A, Arnes J, Sauer T, Akslen LA, Schlichting E, Børresen-Dale AL, Lönneborg A (2005)
   Early detection of breast cancer based on gene-expression patterns in peripheral blood cells
   Breast Cancer Res, 7 (5), R634-44
   DOI 10.1186/bcr1203, PubMed 16168108

Publications 2004

1. Schou I, Ekeberg Ø, Ruland CM, Sandvik L, Kåresen R (2004)
   Pessimism as a predictor of emotional morbidity one year following breast cancer surgery
   Psychooncology, 13 (5), 309-20
   DOI 10.1002/pon.747, PubMed 15133772

Publications 2002

1. Schou I, Ekeberg Ø, Ruland CM, Kåresen R (2002)
   Do women newly diagnosed with breast cancer and consulting surgeon assess decision-making equally?
   Breast, 11 (5), 434-41
   DOI 10.1054/brst.2002.0454, PubMed 14965708

Publications 1995

1. OPSAHL E (1995)
   THE CROWNING OF ERIC-OF-POMMERANIA AND NORWAYS ROLE IN THE FORMATION OF THE KALMAR-UNION + COMMENTARY ON AN EARLIER ARTICLE BY HAUG,ELDBJORG
   Hist. Tidsskr., 74 (4), 473-491
2. OPSAHL E (1995)
   NORWAY IN UNION IN THE 1300S, PTS 1 AND 2 - NORWEGIAN - BLOM,GA
   Hist. Tidsskr., 74 (4), 519-540